U.S. stocks closed lower on the last day of trade for August as investors digested a volatile month amid uncertainty about China and the Fed.» Read More
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
Following are the day’s biggest winners and losers. Find out why shares of Carnival and Walter Energy popped while Lowe’s and American Airlines dropped.
Market uncertainty has left some as to whether to buy in or get out. Where should investors look to gain profits? Jamie Cox, Managing Partner, Harris Financial Group and Christopher Zook, chairman and CIO of CAZ Investments shared their market insights.
The day after President Obama’s impassioned speech for big-government health care, Wall Street bet heavily that the so-called government-insurance option he supports is dead.
Shares of U.S. health insurers climbed as analysts said Pres. Barack Obama's highly anticipated speech urging Congress to act on health reform revealed no "game changers." Thomas Carroll, analyst at Stifel Nicolaus, and David Joy, chief market strategist at RiverSource Investments, shared their insights on the industry.
President Obama will attempt to reshape the bitter debate about health care reform. How will you know if his speech is a success?
Shares of Aetna, UnitedHealth and other HMO stocks fell on Tuesday as investors came to realize that healthcare reform is squarely back on the table.
Investors are wondering if bullish sentiment will continue well into September after a weak dollar lifted the price of oil, gold and other commodities.
Our traders are good but you knew that! Check out their latest picks that paid in a regular feature we call "Quicker Than The Ticker."
HMO stocks could move next week after President Obama speaks about health care reform before a joint session of Congress.
Virtually every large pharmaceutical company seems to have discovered cancer, and a substantial portion of the smaller biotechnology companies are focused on it as well. Together, the companies are pouring billions of dollars into developing cancer drugs.
Lawrence Glazer, managing director at Mayflower Advisors shared his market insights and told investors where they should be putting their money.
There’s been a lot of speculation and chatter, but can Democrats really take a ‘public option’ off the table as they press ahead with health care reform?
U.S. consumer confidence rebounded in August after back-to-back monthly declines, but will the gains continue to fuel the economy? Robert Loest, portfolio manager at Integrity Growth and Income and Stephen Gallagher, chief U.S. economist at Societe Generale discussed their outlooks for the consumer and the economy.
As the health care debate continues, Todd Weller, health care IT analyst at Stifel Nicolaus, and Les Funtleyder, health care strategist at Miller Tabak, zero in on health care names that may bring healthy returns.
On Monday investors clearly decided it was time to take a breather after a sharp gain in Treasury debt prices drove benchmark yields lower and triggered a sell-off.
With so may investors waiting for a pullback, should you play the market short?
Not having a public option in the Obama healthcare reform bill is good for the the larger managed care group, says health care analyst Thomas Carroll of Stifel Nicoluas.
The market bounced back on Tuesday against all odds, just like the Mad Money host said it would.
As public support for healthcare reform cools, healthcare stocks are heating up. But could gains be short lived?